SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-022201
Filing Date
2024-02-02
Accepted
2024-02-02 06:05:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d732657dsc13ga.htm SC 13G/A 32580
  Complete submission text file 0001193125-24-022201.txt   34170
Mailing Address 7 TIMES SQUARE 42ND FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 42ND FLOOR NEW YORK NY 10036 800-541-5156
TimesSquare Capital Management, LLC (Filed by) CIK: 0001313816 (see all company filings)

IRS No.: 201665304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91774 | Film No.: 24588702
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)